1. Medtech Insight
  2. >>Business
  3. >>Strategy

InPhact Inc.

InPhact aims to combine teleradiology with picture archiving and communications systems (PACS). The teleradiology services use the web to get images to radiologists in diagnostic form and to referring physicians in review form. Unlike the new applications service providers (ASPs), InPhact goes further, not only managing the transmission and storage of images on line, but also the on-line transmission of other radiology services, such as billing, data-collection, transcription. The four-year-old company has raised $14 million, and includes among its investors GE Medical Systems and MDS Capital.

In the mid-1990s, teleradiology held promise as a way of connecting hospitals with clinics and radiologists in remote locations. Teleradiology would allow managed care organizations to select high-quality providers at low cost and keep services and dollars within their systems. It was also convenient for general radiologists to provide night, weekend, and vacation coverage and to allow them to participate on weekends or evenings in making initial emergency diagnoses at home. The radiologists would still have to go to the hospital, but not in such a rush.

Jeffrey Landman, MD, a successful neuroradiologist and founder and chairman of two outpatient imaging centers, was experimenting with beta sites...

Welcome to Medtech Insight

Create an account to read this article

Already a subscriber?

More from Strategy

Apreo Health Raises $130M, First Patient Treated In US Clinical Trial

 
• By Natasha Barrow

Apreo Health CEO Karun Naga talks to Medtech Insight about the company’s intentions for its Series B funding. The Breathe-3 clinical trial and early commercialization activities, involving physician education, are top priorities.

Exact Sciences Reveals Thinking On CRC Liquid Biopsy After Freenome Deal

 
• By Natasha Barrow

Exact Sciences has entered into an exclusive licensing agreement with Freenome, stipulating clinical benchmarks and a first-line rating in the USPSTF guidelines. Medtech Insight interviewed screening CMO Paul Limburg about CRC screening and Exact’s strategy on liquid biopsy.

Fresh Off $100M IPO, Carlsmed Plans For Growth, 2026 Launch Of Customized Cervical Fusion Implant

 
• By Marion Webb

Fresh off an IPO, spinal implant maker Carlsmed is preparing to launch a new cervical fusion application for its aprevo tech. Medtech Insight has two perspectives on these recent moves: CEO Mike Cordonnier and the doctor who performed the first spinal fusion using the technology.

Daye Breaks Into Hormone Self-Testing, Adds New Data To Extensive Gynecology Database

 
• By Natasha Barrow

Daye is launching an at-home reproductive hormone testing service in the UK, utilizing a painless upper arm blood collection method. The product’s UKAS lab accreditation helps build credibility with healthcare providers.

More from Business

Biden-Era Device Trial Snapshot Pilot Halted Amid DEI Policy Shift

 
• By Elizabeth Orr

The FDA's Device Clinical Trial Snapshot Pilot, aimed at increasing trial transparency and diversity, has been canceled following President Trump’s anti-DEI executive order. Critics warn this may hinder trial transparency, impacting public health and demographic data accessibility.

Fresh Off $100M IPO, Carlsmed Plans For Growth, 2026 Launch Of Customized Cervical Fusion Implant

 
• By Marion Webb

Fresh off an IPO, spinal implant maker Carlsmed is preparing to launch a new cervical fusion application for its aprevo tech. Medtech Insight has two perspectives on these recent moves: CEO Mike Cordonnier and the doctor who performed the first spinal fusion using the technology.

Daye Breaks Into Hormone Self-Testing, Adds New Data To Extensive Gynecology Database

 
• By Natasha Barrow

Daye is launching an at-home reproductive hormone testing service in the UK, utilizing a painless upper arm blood collection method. The product’s UKAS lab accreditation helps build credibility with healthcare providers.